NCT00063830View on ClinicalTrials.gov

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 3, 2003

Primary Completion Date

October 11, 2004

Study Completion Date

October 11, 2004

Conditions
Ulcerative Colitis
Interventions
DRUG

Alicaforsen

Trial Locations (1)

Unknown

Sacramento

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY